Cytosolix logo

Cytosolix jobs and careers

About Cytosolix

Cytosolix develops novel oral and IV derivatives that target tumor acidity to improve the efficacy of small molecule cancer therapeutics.

Founded in 2017 by John Deacon.

Founded
2017
Employees
1 to 10
Total funding
$6.8M